1 / 55

Hepatitis A

Hepatitis A. Vaccination Offers Long-Term Immunity. The Hepatitis A Virus. The HAV Replication Cycle. Hepatitis A. Transmission is typically by the faecal-oral route: Contamination of food or water Close person-to-person contact Sexual oral-anal contact

damian-lott
Download Presentation

Hepatitis A

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hepatitis A Vaccination Offers Long-Term Immunity

  2. The Hepatitis A Virus

  3. The HAV Replication Cycle

  4. Hepatitis A • Transmission is typically by the faecal-oral route: • Contamination of food or water • Close person-to-person contact • Sexual oral-anal contact Less typically, hepatitis A may be transmitted in body fluids such as blood and saliva .

  5. Symptomatic Ratio in Day - Care Children

  6. “ Clinical illness is rare in children infected in the first year of life , occurs in about one - fourth of those under the age of 15, and is almost universal in adults . Gust &Feinstone 1990

  7. Symptoms of Hepatitis A in Children & Adults

  8. Complications of Hepatitis A • Cholestatic Joundice • Relapsing Hepatitis • Fulminant Hepatitis

  9. Hepatitis A: Clinical Characteristics of Patients by Age Group Clinical Characteristics <1-14yrs 15-39yrs 40+yrs (n=1692) (n=4918) (n=1386) Jaundice 81.7% 86.8% 70.3% Hospitalised for Hepatitis 17.1% 32.2% 70.3% Death as a result of Hepatitis 0.1% 0.3% 2.1%

  10. “As there is no specific treatment for hepatitis A, management is basically Supportive…”Dr lan D Gust & Dr Sptephen M Feinstone

  11. Highly developed countries , such as japan , Australia , and most parts of North America and Europe , are largely low endemicity regions for hepatitis A Many residents of these areas have no natyral immunity against hepatitis A virus

  12. Morbidity & Mortality per 100,000 Unprotected Travellers to Developing Countries per Month of Stay Abroad INFECTION Morbidity Case Fatality rate(%) Mortality ______________________________________________________________________ Malaria,West Africa 2400 2(for p. falciparum) 40 Malaria ,South America 50 2(for p. falciparum) 0.15 Hepatitis A: generally 300(-600) 0.1 0.3(-0.6) Hepatitis A:backpackers 2000 0.1 2 Hepatitis B:expatriates 80(-240) 2 1.6(-4.8) Typhoid fever : usual destination 3 1 0.03 Typhoid : India , N-,W-Africa 30 1 0.3 Ppliomyelitis : symptomatic 0.1 20 0.02 Poliomyelitis: Symptomatic 0.1 20 0.02 Poliomyelitis: asymptomatic 2(-100) - (contacts) Cholera 0.3 2 0.006

  13. Travellers at Risk of HAV Infection • Tourists • Business travellers • Foreign aid workers • Airline Personnel • Missionaries • Professionals working abroad

  14. “Symptomatic hepatitis A is the most frequently occurring immunisable infection in travellers”“The incidence rate of symptomatic hepatitis A for a one month journey from an industrialised country to a developing country is 3/1000 for the usual non-immune traveller” “This applies also to tourists staying in renowned hotels”

  15. Uk Travellers Abroad Protection is advised for non-immune Travellers from the UK visiting all countries Outside of Northern Europe, North America, New Zealand and Australia

  16. “ In unprotected travellers , hepatitis A occurs 40 times more frequently than typhoid fever and 800 times more frequently than cholera” Steffen 1991

  17. This availabillity of an effective hepatitis A vaccine will make it possible , at last, to provide protection against one of the oldest disease threats to the healthy soldier Col WH Bancroft MD Walter Reed Army Institute,washington DC

  18. This enhanced risk of hepatitis Ainfection for the nursing profession … prompts us to demand that (this type of disease) should also of professional diseases Windorfer et al 1989

  19. Hepatitis A in both employees and household contacts is strongly related to contact with children whoo attend day-care centre Hadler et al 1980

  20. Protection is advised for close contacts of all ages in order to control outbreaks of hepatitis A in households and in institutions Joint Committee on Vaccination and Immunisation

  21. Prevention of Hepatitis A • Improvement in water Supply, sanitation and hygiene • Isolation of infected individuals • Passive immunisation (IG) • Active immunisation ( vaccination)

  22. Passive Immunisation • Short –term protection- requires frequent renewal • No stimulation of antibody production in recipient • Plasma- derived product • Large injection volumes

  23. Active Vaccination • Long –term immunity from active vaccination • Stimulates antibody production in the recipient • Non plasma-derived product • Small IM injection volumes administered via deltoid

  24. Recombinant Vaccines • HAV epitope is complex • Current technology has not been able to reproduce the epitope in isolation • The development of a recombinant vaccine against hepatitis A will be very difficult

  25. Live, Attenuated Vaccines • Difficult to develop • Under-attenuation may lead to active infection • Over-attenuation may lead to vaccine failure • Re-emergence infection in both recipient and close contacts

  26. Inactivated Vaccine • Killed virus – incapable of causing active infection • Killed Virus – possesses the antigens which stimulate the production of anti-HAV • Can be developed using proven technology (polio, salk)

More Related